Literature DB >> 25485493

p27(Kip1) and STMN1: partners again?

George F Atweh1, Camelia Iancu-Rubin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25485493      PMCID： PMC4613596          DOI： 10.4161/15384101.2014.966580

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  7 in total

Review 1.  p27Kip1 metabolism: a fascinating labyrinth.

Authors:  Adriana Borriello; Valeria Cucciolla; Adriana Oliva; Vincenzo Zappia; Fulvio Della Ragione
Journal:  Cell Cycle       Date:  2007-05-13       Impact factor: 4.534

2.  p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion.

Authors:  Gustavo Baldassarre; Barbara Belletti; Milena S Nicoloso; Monica Schiappacassi; Andrea Vecchione; Paola Spessotto; Andrea Morrione; Vincenzo Canzonieri; Alfonso Colombatti
Journal:  Cancer Cell       Date:  2005-01       Impact factor: 31.743

Review 3.  Stathmin: a protein with many tasks. New biomarker and potential target in cancer.

Authors:  Barbara Belletti; Gustavo Baldassarre
Journal:  Expert Opin Ther Targets       Date:  2011-10-07       Impact factor: 6.902

Review 4.  Regulation of the cytoskeleton: an oncogenic function for CDK inhibitors?

Authors:  Arnaud Besson; Richard K Assoian; James M Roberts
Journal:  Nat Rev Cancer       Date:  2004-12       Impact factor: 60.716

Review 5.  The role of stathmin in the regulation of the cell cycle.

Authors:  Camelia Iancu Rubin; George F Atweh
Journal:  J Cell Biochem       Date:  2004-10-01       Impact factor: 4.429

6.  Contact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent manner.

Authors:  Joshua Armenia; Linda Fabris; Francesca Lovat; Stefania Berton; Ilenia Segatto; Sara D'Andrea; Cristina Ivan; Luciano Cascione; George A Calin; Carlo M Croce; Alfonso Colombatti; Andrea Vecchione; Barbara Belletti; Gustavo Baldassarre
Journal:  Oncotarget       Date:  2014-03-15

7.  Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma.

Authors:  Akira Watanabe; Hideki Suzuki; Takehiko Yokobori; Mariko Tsukagoshi; Bolag Altan; Norio Kubo; Shigemasa Suzuki; Kenichiro Araki; Satoshi Wada; Kenji Kashiwabara; Yasuo Hosouchi; Hiroyuki Kuwano
Journal:  Cancer Sci       Date:  2014-05-27       Impact factor: 6.716
  7 in total
  1 in total

1.  p27/Kip1 functions as a tumor suppressor and oncoprotein in osteosarcoma.

Authors:  Arthur W Currier; E A Kolb; Richard G Gorlick; Michael E Roth; Vidya Gopalakrishnan; Valerie B Sampson
Journal:  Sci Rep       Date:  2019-04-16       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.